165 related articles for article (PubMed ID: 35190359)
1. Relationship between atherogenic index of plasma and stent thrombosis in patients with acute coronary syndrome.
Özcan Abacıoğlu Ö; Yıldırım A; Koyunsever NY; Karadeniz M; Kılıç S
Anatol J Cardiol; 2022 Feb; 26(2):112-117. PubMed ID: 35190359
[TBL] [Abstract][Full Text] [Related]
2. Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
Brener SJ; Cristea E; Kirtane AJ; McEntegart MB; Xu K; Mehran R; Stone GW
JACC Cardiovasc Interv; 2013 Jan; 6(1):36-43. PubMed ID: 23266233
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
[TBL] [Abstract][Full Text] [Related]
4. Association of the CHA2DS2VASc Score with Acute Stent Thrombosis in Patients with an ST Elevation Myocardial Infarction Who Underwent a Primary Percutaneous Coronary Intervention.
Tanık VO; Aruğaslan E; Çinar T; Keskin M; Kaya A; Tekkeşin AI
Med Princ Pract; 2019; 28(2):115-123. PubMed ID: 30448849
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes.
Dangas GD; Claessen BE; Mehran R; Xu K; Fahy M; Parise H; Henriques JP; Ohman EM; White HD; Stone GW
JACC Cardiovasc Interv; 2012 Nov; 5(11):1097-105. PubMed ID: 23174632
[TBL] [Abstract][Full Text] [Related]
6. Incidence, predictors, and clinical outcomes of early stent thrombosis in acute myocardial infarction patients treated with primary percutaneous coronary angioplasty (insights from the University of Ottawa Heart Institute STEMI registry).
Singh K; Rashid M; So DY; Glover CA; Froeschl M; Hibbert B; Chong AY; Dick A; Labinaz M; Le May M
Catheter Cardiovasc Interv; 2018 Apr; 91(5):842-848. PubMed ID: 28733995
[TBL] [Abstract][Full Text] [Related]
7. The Pt-Cr everolimus-eluting stent with bioabsorbable polymer in the treatment of patients with acute coronary syndromes. Results from the SYNERGY ACS registry.
de la Torre Hernandez JM; Moreno R; Gonzalo N; Rivera R; Linares JA; Veiga Fernandez G; Gomez Menchero A; Garcia Del Blanco B; Hernandez F; Benito Gonzalez T; Subinas A; Escaned J
Cardiovasc Revasc Med; 2019 Aug; 20(8):705-710. PubMed ID: 30414798
[TBL] [Abstract][Full Text] [Related]
8. Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Tunçez A; Çetin MS; Çetin EHÖ; Yilmaz S; Korkmaz A; Uçar FM
Medicine (Baltimore); 2017 Feb; 96(5):e5986. PubMed ID: 28151892
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Drug-Eluting Stent Thrombosis After Treatment for Acute Versus Chronic Coronary Syndrome.
Yamamoto F; Natsuaki M; Kuramitsu S; Ohya M; Otake H; Horie K; Yamanaka F; Shiomi H; Nakazawa G; Ando K; Kadota K; Saito S; Kimura T; Node K;
JACC Cardiovasc Interv; 2021 May; 14(10):1082-1090. PubMed ID: 34016404
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Ma X; Sun Y; Cheng Y; Shen H; Gao F; Qi J; Yang L; Wang Z; Shi D; Liu Y; Liu X; Zhou Y
Lipids Health Dis; 2020 Nov; 19(1):240. PubMed ID: 33198752
[TBL] [Abstract][Full Text] [Related]
11. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ
Int J Cardiovasc Imaging; 2020 May; 36(5):789-796. PubMed ID: 31919706
[TBL] [Abstract][Full Text] [Related]
12. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.
Godschalk TC; Byrne RA; Adriaenssens T; Malik N; Feldman LJ; Guagliumi G; Alfonso F; Neumann FJ; Trenk D; Joner M; Schulz C; Steg PG; Goodall AH; Wojdyla R; Dudek D; Wykrzykowska JJ; Hlinomaz O; Zaman AG; Curzen N; Dens J; Sinnaeve P; Desmet W; Gershlick AH; Kastrati A; Massberg S; Ten Berg JM;
JACC Cardiovasc Interv; 2017 Dec; 10(24):2548-2556. PubMed ID: 29268884
[TBL] [Abstract][Full Text] [Related]
13. Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study.
Généreux P; Redfors B; Witzenbichler B; Maehara A; Yadav M; Weisz G; Francese DP; Parvataneni R; Brener SJ; Mehran R; Kirtane AJ; Stone GW
Catheter Cardiovasc Interv; 2017 Jan; 89(1):26-35. PubMed ID: 26813732
[TBL] [Abstract][Full Text] [Related]
14. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
15. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
[TBL] [Abstract][Full Text] [Related]
16. Factors Impacting Stent Thrombosis in Patients With Percutaneous Coronary Intervention and Coronary Stenting: A Systematic Review and Meta-Analysis.
Nso N; Nassar M; Zirkiyeva M; Mbome Y; Lyonga Ngonge A; Badejoko SO; Akbar S; Azhar A; Lakhdar S; Guzman Perez LM; Abdalazeem Y; Rizzo V; Munira M
Cureus; 2022 Apr; 14(4):e23973. PubMed ID: 35547463
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, correlation and clinical outcome of intra-procedural stent thrombosis in patients undergoing primary percutaneous coronary intervention for acute coronary syndrome.
Xu Y; Qu X; Fang W; Chen H
J Interv Cardiol; 2013 Jun; 26(3):215-20. PubMed ID: 23551235
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1).
Saleh A; Hammoudeh A; Tabbalat R; Al-Haddad I; Al-Mousa E; Jarrah M; Izraiq M; Nammas A; Janabi H; Hazaymeh L; Shakhatreh A; Khadder Y
Ann Saudi Med; 2016; 36(1):17-22. PubMed ID: 26922683
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
Jiménez VA; Iñiguez A; Baz JA; Valdés M; Ortiz A; Vuilliomenet A; Mainar V; Dudek D; Banai S; Tüller D; Bonnet JL; De Miguel A; Bastos G; Wijns W; Saito S
Cardiovasc Revasc Med; 2016 Sep; 17(6):355-61. PubMed ID: 27156201
[TBL] [Abstract][Full Text] [Related]
20. Stent thrombosis in acute coronary syndromes: Patient-related factors and operator-related factors.
Kamenik M; Widimsky P
Anatol J Cardiol; 2020 Oct; 24(4):274-279. PubMed ID: 33001053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
